Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) Short Interest Update

Cuprina Holdings (Cayman) LTD (NASDAQ:CUPR) was the recipient of a significant drop in short interest during the month of August. As of August 31st, there was short interest totaling 1,089 shares, a drop of 90.3% from the August 15th total of 11,255 shares. Approximately 0.1% of the company’s stock are short sold. Based on an average daily trading volume, of 12,371 shares, the days-to-cover ratio is currently 0.1 days.

Cuprina Holdings (Cayman) Price Performance

NASDAQ CUPR traded up $0.09 on Thursday, reaching $3.00. The company had a trading volume of 8,524 shares, compared to its average volume of 44,311. The company’s fifty day moving average is $3.48 and its 200 day moving average is $3.21. Cuprina Holdings has a 52-week low of $1.76 and a 52-week high of $14.80. The company has a current ratio of 2.35, a quick ratio of 2.35 and a debt-to-equity ratio of 0.07.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings raised shares of Cuprina Holdings (Cayman) from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday, August 26th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Cuprina Holdings (Cayman) has an average rating of “Sell”.

Cuprina Holdings (Cayman) Company Profile

We are a Singapore-based biomedical and biotechnology company that is dedicated to the development and commercialization of innovative products for the management of chronic wounds, as well as operating in the health and beauty sectors. Our expertise in biomedical research allows us to identify and utilize materials derived from natural sources to develop wound care products in the form of medical devices which meet international standards. We believe we will be able to build upon and leverage such expertise to develop innovative cosmeceutical products in the future.